295 related articles for article (PubMed ID: 19445682)
1. Brain natriuretic peptide levels have diagnostic and prognostic capability for cardio-renal syndrome type 4 in intensive care unit patients.
Park S; Cho GY; Kim SG; Hwang YI; Kang HR; Jang SH; Kim DG; Song YR; Bae YA; Jung KS
Crit Care; 2009; 13(3):R70. PubMed ID: 19445682
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Asymptomatic Brain Natriuretic Peptide Elevation at Nephrology Referral in Patients with Chronic Kidney Disease.
Hayashi T; Yasuda K; Kimura T; Sasaki K; Shimada K; Hashimoto N; Isaka Y
Am J Nephrol; 2018; 48(3):205-213. PubMed ID: 30196305
[TBL] [Abstract][Full Text] [Related]
3. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
[TBL] [Abstract][Full Text] [Related]
4. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
[TBL] [Abstract][Full Text] [Related]
6. B-type natriuretic peptide may predict prognosis in older adults admitted with a diagnosis other than heart failure.
Di Marca S; Rando A; Cataudella E; Pulvirenti A; Alaimo S; Terranova V; Corriere T; Pisano M; Di Quattro R; Ronsisvalle ML; Giraffa CM; Giordano M; Stancanelli B; Malatino L
Nutr Metab Cardiovasc Dis; 2018 Jun; 28(6):636-642. PubMed ID: 29625779
[TBL] [Abstract][Full Text] [Related]
7. Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels.
Valle R; Aspromonte N; Milani L; Peacock FW; Maisel AS; Santini M; Ronco C
Heart Fail Rev; 2011 Nov; 16(6):519-29. PubMed ID: 21604179
[TBL] [Abstract][Full Text] [Related]
8. The predictability of renin-angiotensin-aldosterone system factors for clinical outcome in patients with acute decompensated heart failure.
Nakada Y; Takahama H; Kanzaki H; Sugano Y; Hasegawa T; Ohara T; Amaki M; Funada A; Yoshida A; Yasuda S; Ogawa H; Anzai T
Heart Vessels; 2016 Jun; 31(6):925-31. PubMed ID: 25964073
[TBL] [Abstract][Full Text] [Related]
9. Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients.
Sundqvist S; Larson T; Cauliez B; Bauer F; Dumont A; Le Roy F; Hanoy M; Fréguin-Bouilland C; Godin M; Guerrot D
PLoS One; 2016; 11(8):e0159914. PubMed ID: 27548064
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Impact of BNP Variations in Patients Admitted for Acute Decompensated Heart Failure with In-Hospital Worsening Renal Function.
Stolfo D; Stenner E; Merlo M; Porto AG; Moras C; Barbati G; Aleksova A; Buiatti A; Sinagra G
Heart Lung Circ; 2017 Mar; 26(3):226-234. PubMed ID: 27523462
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of B-type natriuretic peptide for estimating left atrial size and its usefulness for predicting all-cause mortality and cardiovascular events among chronic haemodialysis patients.
Ishigami J; Iimori S; Kuwahara M; Sasaki S; Tsukamoto Y
Nephrology (Carlton); 2014 Dec; 19(12):777-83. PubMed ID: 25142830
[TBL] [Abstract][Full Text] [Related]
12. Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure.
Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Verdiani V; Tijssen JG; Pinto YM
JACC Heart Fail; 2015 Oct; 3(10):751-61. PubMed ID: 26449995
[TBL] [Abstract][Full Text] [Related]
13. In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study.
Di Somma S; Magrini L; Pittoni V; Marino R; Mastrantuono A; Ferri E; Ballarino P; Semplicini A; Bertazzoni G; Carpinteri G; Mulè P; Pazzaglia M; Shah K; Maisel A; Clopton P
Crit Care; 2010; 14(3):R116. PubMed ID: 20550660
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
[TBL] [Abstract][Full Text] [Related]
15. The role of B-type natriuretic peptide in diagnosing acute decompensated heart failure in chronic kidney disease patients.
Kadri AN; Kaw R; Al-Khadra Y; Abuamsha H; Ravakhah K; Hernandez AV; Tang WHW
Arch Med Sci; 2018 Aug; 14(5):1003-1009. PubMed ID: 30154881
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of B-type natriuretic peptide and its amino-terminal proBNP fragment for cardiovascular events with stratification by renal function.
Horii M; Matsumoto T; Uemura S; Sugawara Y; Takitsume A; Ueda T; Nakagawa H; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Takeda Y; Kawata H; Kawakami R; Saito Y
J Cardiol; 2013 Jun; 61(6):410-6. PubMed ID: 23618914
[TBL] [Abstract][Full Text] [Related]
17. Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea.
Shah KB; Kop WJ; Christenson RH; Diercks DB; Kuo D; Henderson S; Hanson K; Mehra MR; deFilippi CR
Clin Chem; 2009 Jan; 55(1):59-67. PubMed ID: 18988754
[TBL] [Abstract][Full Text] [Related]
18. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
[TBL] [Abstract][Full Text] [Related]
19. Brain natriuretic peptide at discharge as a predictor of 6-month mortality in acute decompensated heart failure.
Naffaa M; Makhoul BF; Tobia A; Jarous M; Kaplan M; Aronson D; Saliba W; Azzam ZS
Am J Emerg Med; 2014 Jan; 32(1):44-9. PubMed ID: 24210886
[TBL] [Abstract][Full Text] [Related]
20. Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure.
Goonewardena SN; Gemignani A; Ronan A; Vasaiwala S; Blair J; Brennan JM; Shah DP; Spencer KT
JACC Cardiovasc Imaging; 2008 Sep; 1(5):595-601. PubMed ID: 19356487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
